Research team has confirmed that neurogenic growth factors have a regenerative effect on peripheral nerves that are adversely affected by co-morbidities such as diabetes and HIV. Neurogenic growth factors found in Plasma based treatments have a profound effect on the clinical presentation seen in patients suffering from HIV as well as Diabetes associated peripheral neuropathy. Improved sensory perception, proprioception as well as decreased pain are expected clinical outcomes.
Patient being treated with PlasmaNeu for HIV Associated Neuropathy
Platelet-rich plasma and fibrin matrix when combined with collagen has been found to provide a microscaffold-infrastructure to augment angiogenesis, epithelialization and subsequent wound healing. Acting as a slow-release form of essential growth factors, PRP can be used in conjunction with fibrin matrix for wound optimization. All patients should be screened for adequate vasculatrue, anemia as well as hypoalbuminemia.
Patient being treated with PlasmsGen for chronic diabetic wound.
Platelet-rich plasma contains a variety of growth factors that are essential in the healing process of injured or damaged tissue. PlasmaPro is a mixture of platelet-rich as well as platelet-poor plasma which contains a high concentration of growth factors as well as fibrin which is essential in wound healing. The platelets in PRP are aggregated then activated in a proprietary way to amplify the release of growth factors. PlasmaPro is indicated for mild to moderate osteoarthritis as well as an array of tendinopathies. Additionally, PRP is indicated for chronic non-healing wounds and is used as a wound optimizer when administered in a peri-wound fashion. Angiogenic as well as epithelial growth factors are responsible for rapid wound closure.
Patient being treated with PlasmaPro for moderate shoulder pain.
1. Autologous platelet-rich plasma promotes neurogenic differentiation of human adipose-derived stem cells in vitro